Top Markets
#1 Islamic Coin Islamic Coin +152.28%
#2 Bitway Bitway +55.04%
#3 Starpower Starpower +45.07%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +28.47%
#5 aelf aelf +24.96%
#6 SkyAI SkyAI +16.85%
#7 Pons Pons +15.81%
#8 DAPPOS DAPPOS +14.72%
#9 龙虾 (Lobster) 龙虾 (Lobster) +14.18%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Biotechnologies Assets S.A. Biotechnologies Assets S.A.

Biotechnologies Assets S.A.

BST
Rank in Stocks #29724
Biotechnologies Assets S.A. is dedicated to conceiving, producing, and... Biotechnologies Assets S.A. is dedicated to conceiving, producing, and commercializing sophisticated biotechnological assets. These innovative materials are utilized across a diverse array of sectors, including biopharmaceuticals, agriculture, cosmetics, animal health, and the broader chemical industry. The company operates globally, with its headquarters located in Cádiz, Spain, where it was established in 1954.
Share Price
$0.26569876
Market Cap
$19.92M
Change (1 day)
3.70%
Change (1 year)
-37.35%
Country
ES
Trade Biotechnologies Assets S.A. (BST)

Category

Healthcare
Revenue for Biotechnologies Assets S.A. (BST)
Revenue in Aug 2026 TTM: 0
According to Biotechnologies Assets S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Biotechnologies Assets S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR